Bronchial asthma is a chronic inflammatory disease of the airways characterized by recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing. Inhaled medications play a central role in the management and long-term control of this disease. This article presents a comparative analysis of commonly used inhaled drugs in the treatment of bronchial asthma, including inhaled corticosteroids, short-acting and long-acting beta-agonists, and combination therapies. The effectiveness, safety, and clinical outcomes of these medications are evaluated based on current clinical data. The analysis highlights the advantages and limitations of each inhalation therapy and emphasizes the importance of individualized treatment selection to improve disease control and patients’ quality of life.

Bronchial asthma, inhaled medications, inhaled corticosteroids, beta-agonists, combination therapy, comparative analysis.

Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. Updated 2023.

Barnes P.J. Inhaled corticosteroids in asthma: a review of their pharmacology and clinical efficacy. European Respiratory Journal. 2010;35(3):511–529.

Reddel H.K., et al. Strategies for improving asthma control. The Lancet. 2015;386(9998):1046–1056.

Bateman E.D., et al. Overall asthma control: the relationship between current control and future risk. Journal of Allergy and Clinical Immunology. 2010;125(3):600–608.

O’Byrne P.M., et al. Inhaled corticosteroids and long-acting beta-agonists in asthma management. New England Journal of Medicine. 2009;360:1968–1980.

National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. NIH, 2007.

Lipworth B.J. Systemic adverse effects of inhaled corticosteroid therapy. Archives of Internal Medicine. 1999;159(9):941–955.

Pauwels R.A., et al. Long-acting beta-agonists in asthma treatment. American Journal of Respiratory and Critical Care Medicine. 1997;155:202–206.

Cazzola M., et al. Pharmacology and therapeutics of bronchodilators. Pharmacological Reviews. 2012;64(3):450–504.

Peters S.P., et al. Combination therapy with inhaled corticosteroids and long-acting beta-agonists. Chest. 2006;129(3):536–552.

Horne R., et al. Adherence to inhaled therapy in asthma. Respiratory Medicine. 2007;101(6):1163–1172.

Bousquet J., et al. Asthma management and prevention: clinical evidence. Allergy. 2007;62(2):102–112.

Newman S.P. Inhaler treatment options in asthma. European Respiratory Review. 2005;14(96):102–108.

Masoli M., et al. The global burden of asthma. Allergy. 2004;59(5):469–478.

Price D., et al. Effectiveness of inhaled combination therapy in real-world asthma management. Primary Care Respiratory Journal. 2010;19(3):224–232.